title: Dithiocarbamate treatment of chronic cadmium intoxication in mice.
abstract: The dithiocarbamate analogs, N-benzyl-N-dithiocarboxy-D-glucamine (BDCG) and N-cyclohexyl-N-(2-hydroxy-3-sulfonatopropyl)dithiocarbamate (CAPSO-DTC), were evaluated as cadmium (Cd) antagonists in mice which had received repetitive injections of Cd to effect accumulation of substantial levels of metallothionein-bound Cd in kidneys and livers. BDCG was highly effective in lowering whole body Cd stores and renal Cd concentrations. While the percent of renal Cd mobilized decreased with increasing Cd concentrations, the total amount of Cd mobilized increased. CAPSO-DTC was also effective in reducing whole body Cd levels, but appeared to have less affinity for renal Cd than did BDCG. Treatment of Cd-laden mice with BDCG provoked only a modest elevation of serum creatinine levels, suggesting that the complex of Cd with BDCG may be less nephrotoxic than the complex of Cd with EDTA or dimercaprol. The log of the percent reduction of renal Cd by BDCG was found to be a linear function of the pretreatment renal Cd concentration, and reductions of whole body Cd burdens correlated closely with reductions of liver and kidney Cd concentrations. It was suggested that a Cd complexing agent of the dithiocarbamate class may have ultimate application in a provocative methodology to estimate body or organ Cd stores based upon the amount of Cd excreted following a standard dose of the chelator.
authors.affiliation: Veterans Administration Medical Center, Charleston, SC 29403.
authors.forename: G R
authors.initials: GR
authors.lastname: Gale
authors.forename: L M
authors.initials: LM
authors.lastname: Atkins
authors.forename: A B
authors.initials: AB
authors.lastname: Smith
authors.forename: S G
authors.initials: SG
authors.lastname: Jones
authors.forename: M M
authors.initials: MM
authors.lastname: Jones
mesh_terms: D000818:Animals; D001822:Body Burden; D002104:Cadmium / Q000378:metabolism; D002105:Cadmium Poisoning / Q000188:drug therapy* / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D051379:Mice; D013012:Sorbitol / Q000031:analogs & derivatives*; D013859:Thiocarbamates / Q000627:therapeutic use*
chemical_list: D013859:Thiocarbamates; D002104:Cadmium; C057652:N-cyclohexyl-N-(2-hydroxy-3-sulfonatopropyl)dithiocarbamate; D013012:Sorbitol; D003404:Creatinine; C048763:N-benzylglucamine dithiocarbamate